期刊文献+

复方苦参注射液对肺癌化疗中减毒增效作用的临床观察 被引量:6

The clinical observation of the toxicity attenuation and synergistic effects of Compound Kushen Injection on chemotherapy of lung cancer
原文传递
导出
摘要 目的观察复方苦参注射液(岩舒)在肺癌化疗中的减毒增效作用。方法将64例明确诊断的肺癌患者随机分为两组,治疗组与对照组各32例,均采用相同的化疗方案(小细胞肺癌用EP方案:足叶乙甙+顺铂;非小细胞肺癌用GP方案:吉西他滨+顺铂)及西医对症处理措施,治疗组加用复方苦参注射液静脉点滴,治疗3周期。结果治疗组有效率(CR+PR)56.2%,对照组43.7%,两组比较无统计学意义(P>0.05);治疗组临床受益率(CBR)93.7%,对照组75.0%,两组比较具有统计学意义(P<0.05)。化疗不良反应比较:治疗组与对照组恶心呕吐发生率分别为75.0%和93.7%(P<0.05),便秘发生率分别为28.1%和53.1%(P<0.01),白细胞、血小板下降分别为18.3%和43.7%、15.6%和37.5%(P<0.05);两组治疗后Karnofsky评分改善率分别为50.0%和28.1%,好转稳定率分别为96.8%和79.1%,治疗组高于对照组(P<0.05)。结论复方苦参注射液(岩舒)可提高肺癌患者治疗的总体临床受益率,明显降低化疗的不良反应,提高生活质量。 Objective To observe toxicity attenuation and synergistic effects of Kushen(Radix Sophorae Flaves Centis) Injection on lung cancer chemotherapy.Methods Sixty-four patients with diagnosis of lung cancer were divided into two groups: treatment group and control group of 32 cases each.Same chemotherapy regimen(small cell lung cancer used EP regimen etoposide+ cisplatin;non-small cell lung cancer used GP program:gemcitabine and cisplatin)and symptomatic Western medicine treatment were used.The treatment group was given compound Kushen Injection iv gtt in addition.Three cycles of treatment were given.Results The short-term efficacy(CR+ PR) was 56.2% in treatment group and 43.7% in the control group,there was no significant difference between the two groups(P〉0.05).Clinical benefit rate(CBR)comparison:treatment group 93.7%,control group 75.0%,with statistically significant difference(P〈0.05).Adverse reaction comparison: Incidence of nausea and vomiting in the treatment group and control group were 75.0% and 93.7%(P〈0.05),respectively,constipation rates were 28.1% and 53.1%(P〈0.01),significantly lower in the treatment group,leukopenia and thrombocytopenia were respectively 18.3% and 43.7%,15.6% and 37.5%,lower in treatment group than in control group(P〈0.05);post treatment KPS score improvement rates were 50.0% and 28.1%,stable rates of improvement rate were 96.8% and 79.1%,higher in treatment group than in control group(P〈0.05).Conclusion Compound Kushen Injection could raise the CBR and QOL,and reduce adverse reaction of chemotherapy in patients with lung cancer.
出处 《中国肿瘤临床与康复》 2011年第2期162-164,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 复方苦参注射液 肺肿瘤 减毒增效 生活质量 Compound Kushen Injection Lung neoplasms Toxicity attenuation and synergistic effect Quality of life
  • 相关文献

参考文献8

二级参考文献23

共引文献520

同被引文献44

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部